SUVENPHAR.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 06:00):

Stats
Today's Volume	67 887.00
Average Volume	471 278
Market Cap	164.36B
EPS	INR0 ( 2024-02-05 )
Next earnings date	( INR0 ) 2024-05-22
Last Dividend	INR5.00 ( 2022-09-09 )
Next Dividend	INR0 ( N/A )
P/E	44.25
ATR14	INR0.777 (0.12%)

Volume Correlation

Long: -0.24 (neutral)

Short: -0.04 (neutral)

Signal:(61.775) Neutral

Suven Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Suven Pharmaceuticals Correlation - Currency/Commodity

-0.40
( neutral )

0.14
( neutral )

-0.37
( neutral )

-0.11
( neutral )

-0.38
( neutral )

0.41
( neutral )

Suven Pharmaceuticals Financials

Annual	2022
Revenue:	INR13.40B
Gross Profit:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
Revenue:	INR13.40B
Gross Profit:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
Revenue:	INR12.90B
Gross Profit:	INR7.35B (56.96 %)
EPS:	INR17.83

FY	2021
Revenue:	INR9.80B
Gross Profit:	INR5.60B (57.12 %)
EPS:	INR14.23

Financial Reports:

No articles found.

Suven Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR5.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Suven Pharmaceuticals Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.72 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2021-02-17
Last Dividend	INR5.00	2022-09-09
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR10.00	--
Avg. Dividend % Per Year	0.37%	--
Score	3.55	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.72
Div. Directional Score	7.86	--

Next Divdend (Est)
(2024-07-22)

INR0 Estimate 0.00 %

Dividend Stability

0.11 Bad

Dividend Score

3.55

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2021	INR2.00	0.43%
2022	INR8.00	1.62%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SHIVALIK.NS	Dividend Junior	2023-09-22	Annually	3	0.03%
MANINDS.NS	Dividend Junior	2023-08-14	Annually	20	1.51%
GRASIM.NS	Dividend Junior	2023-08-11	Annually	23	0.31%
BAJAJFINSV.NS	Dividend Junior	2023-06-29	Annually	17	0.03%
UBL.NS	Dividend Junior	2023-08-03	Annually	17	0.27%
POKARNA.NS	Dividend Junior	2023-09-11	Annually	9	0.19%
JMFINANCIL.NS	Dividend Junior	2023-05-19	Annually	18	1.09%
DIXON.NS	Dividend Knight	2023-09-22	Annually	7	0.04%
63MOONS.NS	Dividend Junior	2023-09-20	Annually	20	0.75%
SOUTHBANK.NS	Dividend Junior	2023-08-17	Sporadic	25	0.42%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.318	1.500	3.65	5.47	[0 - 0.5]
returnOnAssetsTTM	0.180	1.200	3.99	4.79	[0 - 0.3]
returnOnEquityTTM	0.201	1.500	8.88	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	26.98	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	20.95	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	17.94	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0168	-1.500	9.72	-10.00	[0 - 0.6]
interestCoverageTTM	94.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.86	2.00	8.07	10.00	[0 - 20]
debtEquityRatioTTM	0.0174	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.587	1.000	3.55	3.55	[0.2 - 0.8]
operatingProfitMarginTTM	0.424	1.000	3.51	3.51	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.85	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.567	0.800	9.55	7.64	[0.5 - 2]
Total Score				12.00

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	45.36	1.000	5.52	0	[1 - 100]
returnOnEquityTTM	0.201	2.50	9.28	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.793	1.500	1.379	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0842	1.000	-0.396	0	[0.1 - 0.5]
Total Score				3.72

Suven Pharmaceuticals

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.